Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-03-05 @ 4:33 AM
Study NCT ID:
NCT01873833
Status:
TERMINATED
Last Update Posted:
2023-10-05
First Post:
2013-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Sponsor:
University of Southern California
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-02
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-06
First Submit QC Date:
None
Study First Post Date:
2013-06-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-11-11
Results First Submit QC Date:
None
Results First Post Date:
2023-10-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-12
Last Update Post Date:
2023-10-05
Last Update Post Date Type:
ACTUAL